

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.93047421 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.93047421 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.61795166 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.61795166 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55892316 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.23928191 |
| 7 | high-density lipoprotein particle remodeling (GO:0034375) | 4.89531567 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.83749483 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.75973731 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.69210288 |
| 11 | protein carboxylation (GO:0018214) | 4.69210288 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.67731188 |
| 13 | urea cycle (GO:0000050) | 4.61397683 |
| 14 | urea metabolic process (GO:0019627) | 4.61397683 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.58138427 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.58138427 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.58138427 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.57758913 |
| 19 | complement activation, alternative pathway (GO:0006957) | 4.51600958 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.42649657 |
| 21 | reverse cholesterol transport (GO:0043691) | 4.36424732 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.32670157 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.31916678 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.22400939 |
| 25 | glyoxylate metabolic process (GO:0046487) | 4.14475189 |
| 26 | protein-lipid complex remodeling (GO:0034368) | 4.14002365 |
| 27 | macromolecular complex remodeling (GO:0034367) | 4.14002365 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 4.14002365 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.13822528 |
| 30 | cysteine metabolic process (GO:0006534) | 4.08958966 |
| 31 | plasma lipoprotein particle clearance (GO:0034381) | 4.07605672 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.07457404 |
| 33 | bile acid metabolic process (GO:0008206) | 4.04194498 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.01424625 |
| 35 | regulation of complement activation (GO:0030449) | 4.01257914 |
| 36 | phospholipid efflux (GO:0033700) | 3.99330719 |
| 37 | lysine metabolic process (GO:0006553) | 3.97946277 |
| 38 | lysine catabolic process (GO:0006554) | 3.97946277 |
| 39 | cholesterol efflux (GO:0033344) | 3.93208829 |
| 40 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.89668680 |
| 41 | triglyceride homeostasis (GO:0070328) | 3.80410555 |
| 42 | acylglycerol homeostasis (GO:0055090) | 3.80410555 |
| 43 | glutamate metabolic process (GO:0006536) | 3.77033212 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.76776086 |
| 45 | tyrosine metabolic process (GO:0006570) | 3.76277796 |
| 46 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.74721348 |
| 47 | plasma lipoprotein particle assembly (GO:0034377) | 3.70969997 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 3.70235720 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.67081483 |
| 50 | negative regulation of sterol transport (GO:0032372) | 3.67081483 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.66116994 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.55645058 |
| 53 | positive regulation of lipid catabolic process (GO:0050996) | 3.54208245 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 3.52909782 |
| 55 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.49990548 |
| 56 | response to methylmercury (GO:0051597) | 3.48524851 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 3.45670894 |
| 58 | cofactor catabolic process (GO:0051187) | 3.45513023 |
| 59 | arginine metabolic process (GO:0006525) | 3.45166740 |
| 60 | protein-lipid complex assembly (GO:0065005) | 3.42770463 |
| 61 | ketone body metabolic process (GO:1902224) | 3.42573939 |
| 62 | synaptic vesicle maturation (GO:0016188) | 3.37781744 |
| 63 | coenzyme catabolic process (GO:0009109) | 3.37779396 |
| 64 | plasma lipoprotein particle organization (GO:0071827) | 3.35308113 |
| 65 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.34890499 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34878422 |
| 67 | negative regulation of lipase activity (GO:0060192) | 3.34232276 |
| 68 | fibrinolysis (GO:0042730) | 3.32223620 |
| 69 | opsonization (GO:0008228) | 3.26980896 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.26370066 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.26176311 |
| 72 | drug catabolic process (GO:0042737) | 3.24766162 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.21957795 |
| 74 | protein-lipid complex subunit organization (GO:0071825) | 3.21234956 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20939982 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.19822055 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.18705712 |
| 78 | indolalkylamine metabolic process (GO:0006586) | 3.18042590 |
| 79 | aldehyde catabolic process (GO:0046185) | 3.14628278 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 3.11450349 |
| 81 | negative regulation of cell killing (GO:0031342) | 3.11228334 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11228334 |
| 83 | complement activation (GO:0006956) | 3.10955546 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.10921127 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.10866610 |
| 86 | protein activation cascade (GO:0072376) | 3.09293640 |
| 87 | synaptic vesicle exocytosis (GO:0016079) | 3.06665663 |
| 88 | cellular glucuronidation (GO:0052695) | 3.06205661 |
| 89 | complement activation, classical pathway (GO:0006958) | 3.04178842 |
| 90 | amine catabolic process (GO:0009310) | 3.02895263 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 3.02895263 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 3.02764858 |
| 93 | imidazole-containing compound metabolic process (GO:0052803) | 3.02112012 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02018248 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00002607 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00002607 |
| 97 | acute-phase response (GO:0006953) | 2.97748480 |
| 98 | cholesterol homeostasis (GO:0042632) | 2.94358868 |
| 99 | sterol homeostasis (GO:0055092) | 2.90598119 |
| 100 | flavonoid metabolic process (GO:0009812) | 2.90383127 |
| 101 | heme transport (GO:0015886) | 2.90165398 |
| 102 | cellular potassium ion homeostasis (GO:0030007) | 2.89872691 |
| 103 | exogenous drug catabolic process (GO:0042738) | 2.89774638 |
| 104 | glutamate secretion (GO:0014047) | 2.87033790 |
| 105 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.86362351 |
| 106 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.86362351 |
| 107 | short-chain fatty acid metabolic process (GO:0046459) | 2.86278131 |
| 108 | ethanol oxidation (GO:0006069) | 2.83523756 |
| 109 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80258736 |
| 110 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.76761250 |
| 111 | positive regulation of Rap GTPase activity (GO:0032854) | 2.73873612 |
| 112 | nerve growth factor signaling pathway (GO:0038180) | 2.66032608 |
| 113 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.60601827 |
| 114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.60478245 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 2.48939945 |
| 116 | L-amino acid import (GO:0043092) | 2.48140193 |
| 117 | regulation of Rap GTPase activity (GO:0032317) | 2.47735385 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45922111 |
| 119 | activated T cell proliferation (GO:0050798) | 2.44166451 |
| 120 | locomotory exploration behavior (GO:0035641) | 2.40496991 |
| 121 | regulation of synaptic vesicle transport (GO:1902803) | 2.36915499 |
| 122 | axon ensheathment in central nervous system (GO:0032291) | 2.35122314 |
| 123 | central nervous system myelination (GO:0022010) | 2.35122314 |
| 124 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.34337159 |
| 125 | adaptation of signaling pathway (GO:0023058) | 2.25655323 |
| 126 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25651539 |
| 127 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.25193654 |
| 128 | regulation of ARF protein signal transduction (GO:0032012) | 2.24936583 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.23284835 |
| 130 | microglial cell activation (GO:0001774) | 2.16767157 |
| 131 | potassium ion homeostasis (GO:0055075) | 2.15114007 |
| 132 | positive regulation of macrophage cytokine production (GO:0060907) | 2.12605477 |
| 133 | regulation of synapse structural plasticity (GO:0051823) | 2.12489273 |
| 134 | potassium ion import (GO:0010107) | 2.10995323 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.10023883 |
| 136 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.09143915 |
| 137 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.07817277 |
| 138 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.07749466 |
| 139 | sodium ion export (GO:0071436) | 2.06575911 |
| 140 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.06417797 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.05576264 |
| 142 | regulation of beta-amyloid formation (GO:1902003) | 2.05411472 |
| 143 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.04119428 |
| 144 | synaptic transmission, glutamatergic (GO:0035249) | 2.04076618 |
| 145 | eosinophil chemotaxis (GO:0048245) | 2.03652448 |
| 146 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.03274334 |
| 147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.02334924 |
| 148 | regulation of T cell tolerance induction (GO:0002664) | 2.02189350 |
| 149 | chondroitin sulfate catabolic process (GO:0030207) | 2.02140747 |
| 150 | macroautophagy (GO:0016236) | 2.01745842 |
| 151 | proline transport (GO:0015824) | 2.00786701 |
| 152 | positive regulation of neurotransmitter transport (GO:0051590) | 2.00574750 |
| 153 | neuronal action potential propagation (GO:0019227) | 1.98124968 |
| 154 | neurotransmitter secretion (GO:0007269) | 1.97481915 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 1.96610108 |
| 156 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 1.96210149 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 1.95925570 |
| 158 | clathrin coat assembly (GO:0048268) | 1.95027192 |
| 159 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.94942447 |
| 160 | response to nerve growth factor (GO:1990089) | 1.94942447 |
| 161 | cellular extravasation (GO:0045123) | 1.94868878 |
| 162 | * ganglioside metabolic process (GO:0001573) | 1.93133735 |
| 163 | negative regulation of interleukin-12 production (GO:0032695) | 1.92689277 |
| 164 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.92175610 |
| 165 | exploration behavior (GO:0035640) | 1.91074444 |
| 166 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 1.90245003 |
| 167 | regulation of natural killer cell mediated immunity (GO:0002715) | 1.90245003 |
| 168 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.89861922 |
| 169 | macrophage activation (GO:0042116) | 1.89055056 |
| 170 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.88702149 |
| 171 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 1.88059047 |
| 172 | phagosome maturation (GO:0090382) | 1.86916184 |
| 173 | positive regulation of antigen processing and presentation (GO:0002579) | 1.86202705 |
| 174 | barbed-end actin filament capping (GO:0051016) | 1.85343518 |
| 175 | neuron-neuron synaptic transmission (GO:0007270) | 1.85186907 |
| 176 | cellular sodium ion homeostasis (GO:0006883) | 1.84776143 |
| 177 | signal complex assembly (GO:0007172) | 1.84653898 |
| 178 | gonadal mesoderm development (GO:0007506) | 1.84597213 |
| 179 | regulation of neurotransmitter secretion (GO:0046928) | 1.84213894 |
| 180 | amino sugar catabolic process (GO:0046348) | 1.83854625 |
| 181 | detection of calcium ion (GO:0005513) | 1.83153117 |
| 182 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.81320836 |
| 183 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.80554786 |
| 184 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 1.80098452 |
| 185 | regulation of macrophage cytokine production (GO:0010935) | 1.79875838 |
| 186 | neuromuscular process controlling posture (GO:0050884) | 1.79651476 |
| 187 | postsynaptic membrane organization (GO:0001941) | 1.79537884 |
| 188 | negative regulation of bone resorption (GO:0045779) | 1.78741520 |
| 189 | pigment cell differentiation (GO:0050931) | 1.78604570 |
| 190 | positive thymic T cell selection (GO:0045059) | 1.78504229 |
| 191 | eosinophil migration (GO:0072677) | 1.77650138 |
| 192 | keratan sulfate catabolic process (GO:0042340) | 1.76576623 |
| 193 | regulation of mononuclear cell migration (GO:0071675) | 1.76209147 |
| 194 | T cell migration (GO:0072678) | 1.75135375 |
| 195 | myeloid cell activation involved in immune response (GO:0002275) | 1.74629561 |
| 196 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 1.74199566 |
| 197 | regulation of calcium-mediated signaling (GO:0050848) | 1.74098161 |
| 198 | regulation of synaptic plasticity (GO:0048167) | 1.73580789 |
| 199 | long-term synaptic potentiation (GO:0060291) | 1.73392935 |
| 200 | regulation of type 2 immune response (GO:0002828) | 1.73086353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.16714631 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72562203 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.74583593 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56216371 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.22735509 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.01538614 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10645696 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09015633 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75731302 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59760121 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.47927322 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36404991 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.33771975 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04494114 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.00638364 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.86976191 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66059482 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59563756 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56846514 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55360232 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54165683 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53038403 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46862087 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46406847 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42391986 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40760316 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37510166 |
| 28 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36452430 |
| 29 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36427776 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35682870 |
| 31 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34410794 |
| 32 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32001251 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31832234 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26691318 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25644963 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.23081773 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22678718 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21192157 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20525692 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20072384 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.18690349 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17319521 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15513085 |
| 44 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14574308 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14164346 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13949494 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13029351 |
| 48 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10902308 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10415159 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10297319 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09655916 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09655916 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09003740 |
| 54 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08535464 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07590725 |
| 56 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07590725 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07261649 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06392310 |
| 59 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05604579 |
| 60 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05316102 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03766476 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03548647 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03165280 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01594341 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00696065 |
| 66 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00682316 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00102764 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99519661 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97463726 |
| 70 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97094813 |
| 71 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97083747 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96886551 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96813249 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95087688 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93518337 |
| 76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91876195 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91354467 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90416312 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90342469 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90076267 |
| 81 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.89683471 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89292424 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89145389 |
| 84 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87454152 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86857572 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86427280 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86276270 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86189190 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86079488 |
| 90 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85276131 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85203765 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85019596 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84747208 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84085554 |
| 95 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84061930 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83977499 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83697800 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83582052 |
| 99 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82768807 |
| 100 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.82259886 |
| 101 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81950311 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81943070 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80707788 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80707788 |
| 105 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79622584 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79191516 |
| 107 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78842365 |
| 108 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78806209 |
| 109 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78612720 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77977755 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77655930 |
| 112 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.77520181 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76922372 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.76815876 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.76677594 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76659740 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.75947152 |
| 118 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73762726 |
| 119 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.73570854 |
| 120 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.73526098 |
| 121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.73493607 |
| 122 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73181662 |
| 123 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72160145 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.68410970 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67135819 |
| 126 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.66728622 |
| 127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66476904 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65615236 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65054253 |
| 130 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.64983879 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64939636 |
| 132 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.64919385 |
| 133 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64785020 |
| 134 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.63894193 |
| 135 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.63687197 |
| 136 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63449460 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.63433210 |
| 138 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.63214381 |
| 139 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63068619 |
| 140 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62693706 |
| 141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61644312 |
| 142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.61391146 |
| 143 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.61202689 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.60989426 |
| 145 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.60974650 |
| 146 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.60925323 |
| 147 | P300_19829295_ChIP-Seq_ESCs_Human | 0.60869087 |
| 148 | RXR_22108803_ChIP-Seq_LS180_Human | 0.60275801 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60131738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.76603682 |
| 2 | MP0005360_urolithiasis | 5.67538431 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.23127635 |
| 4 | MP0005365_abnormal_bile_salt | 4.68589585 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.37722380 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 3.42444801 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.32321834 |
| 8 | MP0005083_abnormal_biliary_tract | 3.30000905 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.16647039 |
| 10 | MP0003252_abnormal_bile_duct | 2.98532683 |
| 11 | MP0009840_abnormal_foam_cell | 2.93777376 |
| 12 | MP0003195_calcinosis | 2.73752837 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.57331059 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.55290269 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.45420996 |
| 16 | MP0005332_abnormal_amino_acid | 2.11807712 |
| 17 | MP0005171_absent_coat_pigmentation | 2.08138922 |
| 18 | MP0005671_abnormal_response_to | 2.05130258 |
| 19 | MP0000920_abnormal_myelination | 2.04825469 |
| 20 | MP0003724_increased_susceptibility_to | 2.02513863 |
| 21 | MP0000604_amyloidosis | 1.93937769 |
| 22 | * MP0002118_abnormal_lipid_homeostasis | 1.88732766 |
| 23 | MP0000609_abnormal_liver_physiology | 1.80538369 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.78028548 |
| 25 | MP0005387_immune_system_phenotype | 1.75974654 |
| 26 | MP0001790_abnormal_immune_system | 1.75974654 |
| 27 | MP0003329_amyloid_beta_deposits | 1.75859540 |
| 28 | MP0004147_increased_porphyrin_level | 1.72556538 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.69584417 |
| 30 | MP0009785_altered_susceptibility_to | 1.66456104 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.65450905 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.64167256 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.62857496 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.61938272 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.60848716 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59113216 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.55450508 |
| 38 | MP0002419_abnormal_innate_immunity | 1.53483168 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.53361532 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.51966989 |
| 41 | MP0003075_altered_response_to | 1.50105381 |
| 42 | MP0008569_lethality_at_weaning | 1.47656945 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.43665606 |
| 44 | MP0000685_abnormal_immune_system | 1.41428330 |
| 45 | MP0005025_abnormal_response_to | 1.39428997 |
| 46 | MP0003868_abnormal_feces_composition | 1.36509060 |
| 47 | MP0009745_abnormal_behavioral_response | 1.31322302 |
| 48 | MP0003880_abnormal_central_pattern | 1.31107661 |
| 49 | MP0003690_abnormal_glial_cell | 1.28677476 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.28190677 |
| 51 | MP0001800_abnormal_humoral_immune | 1.27884938 |
| 52 | MP0002064_seizures | 1.27680048 |
| 53 | MP0002723_abnormal_immune_serum | 1.27414243 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.26306042 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.25384023 |
| 56 | MP0001970_abnormal_pain_threshold | 1.24055118 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.23554352 |
| 58 | MP0003634_abnormal_glial_cell | 1.22447857 |
| 59 | MP0003787_abnormal_imprinting | 1.22349642 |
| 60 | MP0004130_abnormal_muscle_cell | 1.22247344 |
| 61 | MP0002822_catalepsy | 1.22239251 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.21925523 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.20536171 |
| 64 | MP0000343_altered_response_to | 1.20236788 |
| 65 | MP0005535_abnormal_body_temperature | 1.19554714 |
| 66 | MP0009764_decreased_sensitivity_to | 1.18654786 |
| 67 | MP0002063_abnormal_learning/memory/cond | 1.18260791 |
| 68 | MP0005310_abnormal_salivary_gland | 1.15587037 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.13224638 |
| 70 | MP0001764_abnormal_homeostasis | 1.12978117 |
| 71 | MP0009046_muscle_twitch | 1.11490742 |
| 72 | MP0001819_abnormal_immune_cell | 1.11091867 |
| 73 | MP0004510_myositis | 1.11085080 |
| 74 | MP0004885_abnormal_endolymph | 1.10630169 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.10527181 |
| 76 | MP0001502_abnormal_circadian_rhythm | 1.10286432 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.10245359 |
| 78 | MP0001968_abnormal_touch/_nociception | 1.08899217 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.08712880 |
| 80 | MP0008874_decreased_physiological_sensi | 1.04076403 |
| 81 | MP0003828_pulmonary_edema | 1.03524394 |
| 82 | MP0001440_abnormal_grooming_behavior | 1.02749460 |
| 83 | MP0002736_abnormal_nociception_after | 1.01610741 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 1.01409649 |
| 85 | MP0003879_abnormal_hair_cell | 0.99826885 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.98820139 |
| 87 | MP0004270_analgesia | 0.97633243 |
| 88 | MP0001958_emphysema | 0.96756921 |
| 89 | MP0003045_fibrosis | 0.96141048 |
| 90 | MP0001905_abnormal_dopamine_level | 0.94651018 |
| 91 | MP0005451_abnormal_body_composition | 0.93391104 |
| 92 | MP0005166_decreased_susceptibility_to | 0.93213128 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.93189489 |
| 94 | MP0003633_abnormal_nervous_system | 0.93132140 |
| 95 | MP0001984_abnormal_olfaction | 0.93126484 |
| 96 | MP0002229_neurodegeneration | 0.92919537 |
| 97 | MP0002405_respiratory_system_inflammati | 0.92400617 |
| 98 | MP0000371_diluted_coat_color | 0.91946567 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.91815047 |
| 100 | MP0002971_abnormal_brown_adipose | 0.91677380 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.90831824 |
| 102 | MP0000598_abnormal_liver_morphology | 0.90072776 |
| 103 | MP0009763_increased_sensitivity_to | 0.89778808 |
| 104 | MP0001851_eye_inflammation | 0.89292389 |
| 105 | MP0008872_abnormal_physiological_respon | 0.89146322 |
| 106 | MP0003303_peritoneal_inflammation | 0.88196679 |
| 107 | MP0008469_abnormal_protein_level | 0.87375089 |
| 108 | * MP0002078_abnormal_glucose_homeostasis | 0.86872944 |
| 109 | MP0002090_abnormal_vision | 0.86767440 |
| 110 | MP0002572_abnormal_emotion/affect_behav | 0.85217576 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.83852463 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.83363350 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.81027689 |
| 114 | * MP0009642_abnormal_blood_homeostasis | 0.80840162 |
| 115 | MP0004858_abnormal_nervous_system | 0.79876522 |
| 116 | MP0005647_abnormal_sex_gland | 0.79813786 |
| 117 | MP0009697_abnormal_copulation | 0.79339378 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.79208332 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.78933485 |
| 120 | MP0003436_decreased_susceptibility_to | 0.78825705 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.78538323 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.77169150 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.77043308 |
| 124 | MP0004381_abnormal_hair_follicle | 0.75713314 |
| 125 | MP0003091_abnormal_cell_migration | 0.75343865 |
| 126 | MP0002557_abnormal_social/conspecific_i | 0.75138274 |
| 127 | MP0003186_abnormal_redox_activity | 0.74910386 |
| 128 | MP0004924_abnormal_behavior | 0.74530709 |
| 129 | MP0005386_behavior/neurological_phenoty | 0.74530709 |
| 130 | MP0005448_abnormal_energy_balance | 0.74004221 |
| 131 | MP0003631_nervous_system_phenotype | 0.73988511 |
| 132 | MP0002933_joint_inflammation | 0.73428503 |
| 133 | MP0005075_abnormal_melanosome_morpholog | 0.73376046 |
| 134 | MP0003448_altered_tumor_morphology | 0.72073190 |
| 135 | MP0005334_abnormal_fat_pad | 0.70226141 |
| 136 | MP0002272_abnormal_nervous_system | 0.68734112 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.68670544 |
| 138 | MP0006082_CNS_inflammation | 0.65508368 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.63289725 |
| 140 | MP0002735_abnormal_chemical_nociception | 0.61868794 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.61159489 |
| 142 | MP0002067_abnormal_sensory_capabilities | 0.59991989 |
| 143 | MP0002734_abnormal_mechanical_nocicepti | 0.59263264 |
| 144 | MP0002733_abnormal_thermal_nociception | 0.58658548 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.58070965 |
| 146 | MP0003646_muscle_fatigue | 0.58020968 |
| 147 | MP0004883_abnormal_blood_vessel | 0.55567644 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.54551762 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.54450163 |
| 150 | MP0001486_abnormal_startle_reflex | 0.52220952 |
| 151 | MP0004142_abnormal_muscle_tone | 0.52111164 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.51975248 |
| 153 | MP0003011_delayed_dark_adaptation | 0.51847252 |
| 154 | MP0005164_abnormal_response_to | 0.51637660 |
| 155 | MP0003632_abnormal_nervous_system | 0.51417716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.37400100 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.82365461 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.27472707 |
| 4 | Xanthomatosis (HP:0000991) | 5.09550915 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.07359230 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.07359230 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.07359230 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.99985458 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.88704062 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.87220467 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.82016924 |
| 12 | Complement deficiency (HP:0004431) | 4.78021364 |
| 13 | Poikilocytosis (HP:0004447) | 4.03382136 |
| 14 | Joint hemorrhage (HP:0005261) | 3.96692676 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.77893611 |
| 16 | Cholelithiasis (HP:0001081) | 3.74038819 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.73481385 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.66730549 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.66504226 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.60548947 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.59381798 |
| 22 | Abnormal gallbladder morphology (HP:0012437) | 3.58891830 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.58525208 |
| 24 | Abnormality of complement system (HP:0005339) | 3.56174818 |
| 25 | Ketosis (HP:0001946) | 3.55344661 |
| 26 | Reticulocytosis (HP:0001923) | 3.55151109 |
| 27 | Acanthocytosis (HP:0001927) | 3.54213417 |
| 28 | Hyperbilirubinemia (HP:0002904) | 3.52099598 |
| 29 | Mutism (HP:0002300) | 3.51307744 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 3.50426428 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49103724 |
| 32 | Epidermoid cyst (HP:0200040) | 3.44213795 |
| 33 | Cholecystitis (HP:0001082) | 3.43505528 |
| 34 | Abnormal gallbladder physiology (HP:0012438) | 3.43505528 |
| 35 | Hyperammonemia (HP:0001987) | 3.42545878 |
| 36 | Action tremor (HP:0002345) | 3.31397687 |
| 37 | Abnormality of binocular vision (HP:0011514) | 3.27243726 |
| 38 | Diplopia (HP:0000651) | 3.27243726 |
| 39 | Atonic seizures (HP:0010819) | 3.18264335 |
| 40 | Papilledema (HP:0001085) | 3.16147207 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.15757691 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.15757691 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.15757691 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.15418313 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 3.13608075 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.10506611 |
| 47 | Mucopolysacchariduria (HP:0008155) | 3.09654742 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09654742 |
| 49 | Abnormality of macrophages (HP:0004311) | 3.08737106 |
| 50 | Hemiplegia (HP:0002301) | 3.07419283 |
| 51 | Febrile seizures (HP:0002373) | 3.03192195 |
| 52 | Hypercholesterolemia (HP:0003124) | 3.03063417 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00602860 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97258485 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97208838 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91339214 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.89388525 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85722610 |
| 59 | Glomerulonephritis (HP:0000099) | 2.80567617 |
| 60 | Spontaneous abortion (HP:0005268) | 2.74916517 |
| 61 | Focal motor seizures (HP:0011153) | 2.74749774 |
| 62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73242603 |
| 63 | Fat malabsorption (HP:0002630) | 2.72125635 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.71628161 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.70880084 |
| 66 | Hyperglycinemia (HP:0002154) | 2.67761795 |
| 67 | Abnormality of the gallbladder (HP:0005264) | 2.67603551 |
| 68 | Ketoacidosis (HP:0001993) | 2.65724439 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.63698773 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.58700524 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.57509965 |
| 72 | Amyloidosis (HP:0011034) | 2.54519754 |
| 73 | Skin nodule (HP:0200036) | 2.52746577 |
| 74 | Increased CSF protein (HP:0002922) | 2.44855996 |
| 75 | Ocular albinism (HP:0001107) | 2.42031678 |
| 76 | Metabolic acidosis (HP:0001942) | 2.39908907 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39620647 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 2.39200410 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.39113610 |
| 80 | Loss of speech (HP:0002371) | 2.39028785 |
| 81 | Myocardial infarction (HP:0001658) | 2.38202890 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.37736718 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.36661005 |
| 84 | Mitral stenosis (HP:0001718) | 2.36565475 |
| 85 | Agitation (HP:0000713) | 2.36019002 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.35586261 |
| 87 | Iris hypopigmentation (HP:0007730) | 2.35450088 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34690960 |
| 89 | Disinhibition (HP:0000734) | 2.32145478 |
| 90 | Peripheral hypomyelination (HP:0007182) | 2.31821023 |
| 91 | * Status epilepticus (HP:0002133) | 2.31562748 |
| 92 | Hyperventilation (HP:0002883) | 2.31193515 |
| 93 | Orchitis (HP:0100796) | 2.30607373 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.29868748 |
| 95 | Hematochezia (HP:0002573) | 2.28895866 |
| 96 | Intention tremor (HP:0002080) | 2.27719058 |
| 97 | Abnormal eating behavior (HP:0100738) | 2.25847920 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.25642821 |
| 99 | Ankle clonus (HP:0011448) | 2.25544581 |
| 100 | Dialeptic seizures (HP:0011146) | 2.25273440 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25189133 |
| 102 | Spontaneous hematomas (HP:0007420) | 2.24842166 |
| 103 | Abnormality of nucleobase metabolism (HP:0010932) | 2.24391748 |
| 104 | Neonatal onset (HP:0003623) | 2.23179779 |
| 105 | Abnormality of glycine metabolism (HP:0010895) | 2.21500688 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21500688 |
| 107 | Apathy (HP:0000741) | 2.18624237 |
| 108 | Akinesia (HP:0002304) | 2.18530006 |
| 109 | Polyphagia (HP:0002591) | 2.18340007 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 2.18221140 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 2.16777298 |
| 112 | Delayed CNS myelination (HP:0002188) | 2.14153339 |
| 113 | Diminished motivation (HP:0000745) | 2.10684363 |
| 114 | Optic neuritis (HP:0100653) | 2.10307605 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 2.10307605 |
| 116 | Neurofibrillary tangles (HP:0002185) | 2.10297727 |
| 117 | Epileptic encephalopathy (HP:0200134) | 2.09683596 |
| 118 | Polycythemia (HP:0001901) | 2.08720317 |
| 119 | Hyperglycinuria (HP:0003108) | 2.08032315 |
| 120 | Myositis (HP:0100614) | 2.07888264 |
| 121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.07523148 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 2.06646046 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 2.06408410 |
| 124 | Stomatitis (HP:0010280) | 2.05352381 |
| 125 | Gout (HP:0001997) | 2.03528655 |
| 126 | Visual hallucinations (HP:0002367) | 2.03508608 |
| 127 | Steatorrhea (HP:0002570) | 2.02445309 |
| 128 | Focal seizures (HP:0007359) | 2.02245669 |
| 129 | T lymphocytopenia (HP:0005403) | 2.01524393 |
| 130 | Myokymia (HP:0002411) | 1.98987400 |
| 131 | Interstitial pulmonary disease (HP:0006530) | 1.98333432 |
| 132 | Truncal ataxia (HP:0002078) | 1.98127685 |
| 133 | Nephritis (HP:0000123) | 1.95848924 |
| 134 | Abnormality of serum amino acid levels (HP:0003112) | 1.95595582 |
| 135 | Confusion (HP:0001289) | 1.95068088 |
| 136 | Menorrhagia (HP:0000132) | 1.94936707 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93449961 |
| 138 | Postural instability (HP:0002172) | 1.93121810 |
| 139 | Axonal loss (HP:0003447) | 1.92881350 |
| 140 | Albinism (HP:0001022) | 1.91496244 |
| 141 | Abnormality of T cell number (HP:0011839) | 1.91228038 |
| 142 | Rapidly progressive (HP:0003678) | 1.89455023 |
| 143 | Spastic diplegia (HP:0001264) | 1.89203868 |
| 144 | Hypoglycemic seizures (HP:0002173) | 1.89185323 |
| 145 | Memory impairment (HP:0002354) | 1.88553602 |
| 146 | Purpura (HP:0000979) | 1.88408165 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.87887853 |
| 148 | Gingival bleeding (HP:0000225) | 1.87167948 |
| 149 | Vasculitis (HP:0002633) | 1.86786310 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.86040543 |
| 151 | * Generalized tonic-clonic seizures (HP:0002069) | 1.84911543 |
| 152 | Recurrent skin infections (HP:0001581) | 1.84190246 |
| 153 | Retinal atrophy (HP:0001105) | 1.84096750 |
| 154 | Blue irides (HP:0000635) | 1.83838303 |
| 155 | Hemoptysis (HP:0002105) | 1.83626216 |
| 156 | Abnormal social behavior (HP:0012433) | 1.82030090 |
| 157 | Impaired social interactions (HP:0000735) | 1.82030090 |
| 158 | Rigidity (HP:0002063) | 1.81960720 |
| 159 | Dementia (HP:0000726) | 1.81956688 |
| 160 | Inappropriate behavior (HP:0000719) | 1.81319559 |
| 161 | Fetal akinesia sequence (HP:0001989) | 1.81269937 |
| 162 | Increased serum ferritin (HP:0003281) | 1.80955916 |
| 163 | Thrombophlebitis (HP:0004418) | 1.78843101 |
| 164 | Cerebral edema (HP:0002181) | 1.77512106 |
| 165 | Progressive cerebellar ataxia (HP:0002073) | 1.77372012 |
| 166 | Generalized hypopigmentation (HP:0007513) | 1.76453093 |
| 167 | Vascular calcification (HP:0004934) | 1.76263669 |
| 168 | Progressive neurologic deterioration (HP:0002344) | 1.76256625 |
| 169 | Absence seizures (HP:0002121) | 1.75621431 |
| 170 | Pulmonary embolism (HP:0002204) | 1.73120933 |
| 171 | Hemiparesis (HP:0001269) | 1.72718355 |
| 172 | * Irritability (HP:0000737) | 1.72513995 |
| 173 | Torticollis (HP:0000473) | 1.72075477 |
| 174 | Poor eye contact (HP:0000817) | 1.71779325 |
| 175 | * Global brain atrophy (HP:0002283) | 1.71700539 |
| 176 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71627667 |
| 177 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71627667 |
| 178 | Lethargy (HP:0001254) | 1.71246273 |
| 179 | Focal dystonia (HP:0004373) | 1.70757150 |
| 180 | * Vomiting (HP:0002013) | 1.69820433 |
| 181 | Frequent falls (HP:0002359) | 1.69406191 |
| 182 | Craniofacial dystonia (HP:0012179) | 1.68868739 |
| 183 | Nuclear cataract (HP:0100018) | 1.66030318 |
| 184 | Restrictive lung disease (HP:0002091) | 1.65512506 |
| 185 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.64622188 |
| 186 | Dysmetria (HP:0001310) | 1.63391920 |
| 187 | Depression (HP:0000716) | 1.62344106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DAPK2 | 3.70199202 |
| 2 | EPHA4 | 3.60840211 |
| 3 | MAP2K4 | 3.06491202 |
| 4 | RIPK4 | 3.02636252 |
| 5 | NTRK3 | 2.99451475 |
| 6 | MAP3K9 | 2.72266440 |
| 7 | BCKDK | 2.52170620 |
| 8 | ERN1 | 2.37399221 |
| 9 | TXK | 2.29701486 |
| 10 | MAP3K4 | 2.27011928 |
| 11 | KSR2 | 2.03134136 |
| 12 | TRIB3 | 1.91012329 |
| 13 | MAP3K13 | 1.80906286 |
| 14 | SIK2 | 1.79703854 |
| 15 | MAP2K7 | 1.71425873 |
| 16 | SIK1 | 1.69783874 |
| 17 | CAMKK1 | 1.69558370 |
| 18 | FRK | 1.68114258 |
| 19 | TAOK3 | 1.63588636 |
| 20 | PKN2 | 1.57098640 |
| 21 | NTRK2 | 1.54847334 |
| 22 | FGFR4 | 1.46517644 |
| 23 | MINK1 | 1.43012211 |
| 24 | BLK | 1.41177131 |
| 25 | PTK2B | 1.34851327 |
| 26 | PAK6 | 1.32900244 |
| 27 | DAPK1 | 1.29295965 |
| 28 | MAP4K1 | 1.28003668 |
| 29 | PLK2 | 1.27806947 |
| 30 | CSK | 1.27713904 |
| 31 | RIPK1 | 1.25126842 |
| 32 | PHKG1 | 1.23441779 |
| 33 | PHKG2 | 1.23441779 |
| 34 | INSRR | 1.19898247 |
| 35 | ARAF | 1.15920617 |
| 36 | ABL2 | 1.15727566 |
| 37 | GRK5 | 1.14502908 |
| 38 | MAPK12 | 1.11674732 |
| 39 | MAPK11 | 1.06551053 |
| 40 | JAK2 | 1.05585810 |
| 41 | MAP3K14 | 1.05504930 |
| 42 | PRKD2 | 1.04827055 |
| 43 | RET | 1.04291335 |
| 44 | PDPK1 | 1.03976297 |
| 45 | NTRK1 | 1.03955969 |
| 46 | ZAP70 | 1.03273981 |
| 47 | MAP3K1 | 1.02221804 |
| 48 | SGK3 | 1.01733048 |
| 49 | CAMKK2 | 1.00074725 |
| 50 | CASK | 0.99830094 |
| 51 | TBK1 | 0.98844287 |
| 52 | UHMK1 | 0.97583073 |
| 53 | PRKCG | 0.96848932 |
| 54 | TYK2 | 0.96662873 |
| 55 | TYRO3 | 0.96146425 |
| 56 | MAP3K5 | 0.95492813 |
| 57 | ADRBK2 | 0.94125799 |
| 58 | FES | 0.92977791 |
| 59 | MAP3K11 | 0.92896964 |
| 60 | KSR1 | 0.92668217 |
| 61 | PINK1 | 0.92152243 |
| 62 | MARK2 | 0.88699181 |
| 63 | PRKCZ | 0.85623263 |
| 64 | SGK2 | 0.85276947 |
| 65 | PDK1 | 0.84719033 |
| 66 | ITK | 0.84524462 |
| 67 | BMPR2 | 0.83881004 |
| 68 | MAP2K1 | 0.83545643 |
| 69 | CDK5 | 0.83536513 |
| 70 | TNK2 | 0.83429391 |
| 71 | JAK1 | 0.82122241 |
| 72 | SGK494 | 0.81150157 |
| 73 | SGK223 | 0.81150157 |
| 74 | CAMK1G | 0.80731961 |
| 75 | FGFR3 | 0.80552241 |
| 76 | TAOK1 | 0.80152156 |
| 77 | MARK1 | 0.80131709 |
| 78 | MAP3K7 | 0.79919056 |
| 79 | FGR | 0.79479685 |
| 80 | ERBB4 | 0.78892275 |
| 81 | MAPK7 | 0.77760411 |
| 82 | OBSCN | 0.77760163 |
| 83 | IKBKE | 0.76701975 |
| 84 | STK38 | 0.73612575 |
| 85 | MST1R | 0.73579267 |
| 86 | MAP3K6 | 0.72974674 |
| 87 | MAP3K12 | 0.72944421 |
| 88 | MOS | 0.72928853 |
| 89 | SGK1 | 0.71709844 |
| 90 | MAP3K2 | 0.70311218 |
| 91 | CAMK2A | 0.69353832 |
| 92 | MAPK13 | 0.66755094 |
| 93 | GRK7 | 0.66278700 |
| 94 | PRKCH | 0.65130173 |
| 95 | PIK3CG | 0.64302096 |
| 96 | GRK6 | 0.64132806 |
| 97 | BMX | 0.64101340 |
| 98 | PKN1 | 0.63787449 |
| 99 | PRKD1 | 0.62727922 |
| 100 | HCK | 0.62625885 |
| 101 | LCK | 0.62356172 |
| 102 | DDR2 | 0.62248608 |
| 103 | PRKACG | 0.61654869 |
| 104 | TAOK2 | 0.60678454 |
| 105 | TGFBR2 | 0.60318709 |
| 106 | JAK3 | 0.60162779 |
| 107 | SIK3 | 0.59872959 |
| 108 | CAMK4 | 0.59837807 |
| 109 | PTK6 | 0.59718967 |
| 110 | FYN | 0.59574449 |
| 111 | CSF1R | 0.59139723 |
| 112 | DAPK3 | 0.59042208 |
| 113 | CAMK2G | 0.56144178 |
| 114 | CDC42BPA | 0.55428614 |
| 115 | LYN | 0.54680216 |
| 116 | IKBKB | 0.54582302 |
| 117 | PRKAA2 | 0.54000403 |
| 118 | MAP2K3 | 0.52190503 |
| 119 | FGFR2 | 0.51711652 |
| 120 | ROCK1 | 0.51552476 |
| 121 | PRKCE | 0.51311557 |
| 122 | ROCK2 | 0.50826331 |
| 123 | PDGFRB | 0.50192483 |
| 124 | CAMK1D | 0.50042709 |
| 125 | MAP3K3 | 0.49818739 |
| 126 | RPS6KA3 | 0.48865220 |
| 127 | IRAK3 | 0.48691323 |
| 128 | RPS6KA2 | 0.48590419 |
| 129 | ERBB2 | 0.48202157 |
| 130 | PRPF4B | 0.47967029 |
| 131 | PTK2 | 0.45778361 |
| 132 | PRKAA1 | 0.44748326 |
| 133 | PRKD3 | 0.43904352 |
| 134 | STK11 | 0.43593040 |
| 135 | PAK3 | 0.43112212 |
| 136 | PRKCQ | 0.42333304 |
| 137 | MAPK4 | 0.41807622 |
| 138 | SYK | 0.41795342 |
| 139 | EGFR | 0.40009034 |
| 140 | EPHB1 | 0.39491115 |
| 141 | CAMK1 | 0.38428203 |
| 142 | RAF1 | 0.38250601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18464793 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.97504181 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64818699 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.21077733 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.84780126 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78625840 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52012636 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36435971 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16828823 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13545082 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09924448 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86136139 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82779382 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81042856 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.79401514 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78860970 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73548410 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.72584072 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.69598484 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65518996 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61809238 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60297123 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58875641 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58274796 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58205708 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57528472 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54423491 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53879430 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49420479 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45883083 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41156252 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40295484 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38761655 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36519482 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35427175 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34737205 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33228066 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31735949 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30942176 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29959269 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.26283774 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23870829 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.23229822 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.23073019 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22015875 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21747875 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.18608872 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18369043 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17736309 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17370247 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16365757 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14692986 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12001176 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10911340 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10203514 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08124015 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06461266 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06357529 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05979188 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05332816 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04105139 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02822227 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01417402 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00622078 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00508639 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98185413 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94382849 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93774194 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92816263 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91685656 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90559518 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88774029 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86706655 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85876410 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85482797 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85083509 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85047914 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84739222 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.82652129 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82047059 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81572765 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80687652 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79603394 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79445977 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79388046 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79278331 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.78696744 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.78551705 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77889388 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76331246 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76248858 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76124456 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75542375 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75359393 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.75094950 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.74440375 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74389829 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74226738 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73001899 |
| 100 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72655145 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72273124 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.72093645 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71434134 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70337296 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.68553460 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67884069 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67518405 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.67100960 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.67046332 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66025035 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64952913 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64704263 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63794460 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63297046 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62999837 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62948893 |
| 117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61919865 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.61597808 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61044460 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60622009 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59394784 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58769426 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58640864 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57745704 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57017622 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56292550 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55985398 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55770138 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55427683 |
| 130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55172383 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54384164 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53997211 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49725749 |
| 134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48508155 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48503337 |
| 136 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48429912 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47493230 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.47185200 |
| 139 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46203249 |
| 140 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46164855 |
| 141 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46019918 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45642266 |
| 143 | Morphine addiction_Homo sapiens_hsa05032 | 0.43674738 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.42261866 |
| 145 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42143940 |
| 146 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41944801 |
| 147 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41539967 |
| 148 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39161740 |
| 149 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38429277 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38274197 |
| 151 | Salivary secretion_Homo sapiens_hsa04970 | 0.37232493 |
| 152 | Olfactory transduction_Homo sapiens_hsa04740 | 0.35283707 |
| 153 | Insulin secretion_Homo sapiens_hsa04911 | 0.31897956 |
| 154 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30731759 |
| 155 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30048482 |
| 156 | Renin secretion_Homo sapiens_hsa04924 | 0.28019143 |
| 157 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26675135 |
| 158 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24313187 |
| 159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23913784 |
| 160 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21390963 |
| 161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20535787 |
| 162 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19157338 |
| 163 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18827492 |
| 164 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18169723 |
| 165 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.17516112 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17395206 |
| 167 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17296911 |
| 168 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.17073476 |
| 169 | Pertussis_Homo sapiens_hsa05133 | 0.14969863 |
| 170 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.14600359 |
| 171 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14115932 |

